| __timestamp | BioMarin Pharmaceutical Inc. | Corcept Therapeutics Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 621276000 | 25669000 |
| Thursday, January 1, 2015 | 737887000 | 48925000 |
| Friday, January 1, 2016 | 907234000 | 79263000 |
| Sunday, January 1, 2017 | 1071860000 | 155647000 |
| Monday, January 1, 2018 | 1175948000 | 246032000 |
| Tuesday, January 1, 2019 | 1344582000 | 300982000 |
| Wednesday, January 1, 2020 | 1336183000 | 348292000 |
| Friday, January 1, 2021 | 1375760000 | 360697000 |
| Saturday, January 1, 2022 | 1612370000 | 396473000 |
| Sunday, January 1, 2023 | 1842161000 | 475894000 |
| Monday, January 1, 2024 | 2273680000 |
Data in motion
In the competitive landscape of pharmaceuticals, BioMarin Pharmaceutical Inc. and Corcept Therapeutics Incorporated have shown remarkable growth in gross profit over the past decade. Since 2014, BioMarin has consistently outperformed Corcept, with its gross profit increasing by nearly 200% by 2023. This growth trajectory highlights BioMarin's robust market strategy and innovative product pipeline.
Corcept, while trailing behind, has also demonstrated significant progress, with its gross profit surging by over 1,750% during the same period. This impressive growth underscores Corcept's expanding influence in the niche market of cortisol modulation therapies.
The data reveals a compelling narrative of two companies navigating the pharmaceutical industry's challenges and opportunities. As BioMarin continues to leverage its stronghold in rare diseases, Corcept's focus on specialized therapies positions it as a formidable contender in its domain.
Gross Profit Analysis: Comparing Eli Lilly and Company and Corcept Therapeutics Incorporated
Gross Profit Comparison: Johnson & Johnson and Corcept Therapeutics Incorporated Trends
Key Insights on Gross Profit: Novartis AG vs BioMarin Pharmaceutical Inc.
Gross Profit Analysis: Comparing Pfizer Inc. and Corcept Therapeutics Incorporated
Amgen Inc. vs Corcept Therapeutics Incorporated: A Gross Profit Performance Breakdown
Bristol-Myers Squibb Company and Corcept Therapeutics Incorporated: A Detailed Gross Profit Analysis
Gross Profit Comparison: United Therapeutics Corporation and BioMarin Pharmaceutical Inc. Trends
Who Generates Higher Gross Profit? BioMarin Pharmaceutical Inc. or Halozyme Therapeutics, Inc.
Who Generates Higher Gross Profit? BioMarin Pharmaceutical Inc. or Perrigo Company plc
Key Insights on Gross Profit: BioMarin Pharmaceutical Inc. vs HUTCHMED (China) Limited
Corcept Therapeutics Incorporated and BioCryst Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Corcept Therapeutics Incorporated and MiMedx Group, Inc.: A Detailed Gross Profit Analysis